Zobrazeno 1 - 2
of 2
pro vyhledávání: '"64"'
Autor:
Laurent Guilleminault, Lise Rosencher, A. Proust, Arnaud Bourdin, Clairelyne Dupin, S. Fry, Drifa Belhadi, Cécile Chenivesse, Patrick Berger, Frédéric de Blay, Alain Didier, Anne‐Sophie Gamez, Camille Couffignal, Philippe Bonniaud, Gilles Garcia, Camille Taillé, Pierre-Olivier Girodet, Chantal Raherison, Christophe Leroyer, Geneviève Le Bourdellès, Guillaume Mahay
Publikováno v:
Clinical and Experimental Allergy
Clinical and Experimental Allergy, 2020, 50 (7), pp.789-798. ⟨10.1111/cea.13614⟩
Clinical and Experimental Allergy, Wiley, 2020, 50 (7), pp.789-798. ⟨10.1111/cea.13614⟩
Clinical and Experimental Allergy, 2020, 50 (7), pp.789-798. ⟨10.1111/cea.13614⟩
Clinical and Experimental Allergy, Wiley, 2020, 50 (7), pp.789-798. ⟨10.1111/cea.13614⟩
International audience; Background: Dupilumab is a monoclonal anti‐IL‐4Rα antibody developed for the treatment of severe asthma (SA). An early access programme for dupilumab was opened in France in SA patients experiencing unacceptable steroids
Autor:
Marco L. Dottorini, F. Donato, Claudio Tantucci, G. Casucci, P. Bottini, Laura Pini, F. Peccini, B. Bruni
Publikováno v:
Clinical & Experimental Allergy. 37:188-196
Summary Background Cross-sectional studies report an increasing prevalence of allergic diseases, such as rhinitis and asthma. Not thoroughly known, instead, is the natural history of allergic sensitization and the progress of the allergic disease-rel